Vectus Biosystems Ltd has released a press release.
Appendix 4C - Quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Vectus Biosystems Limited on 6ix
Story so far
Earlier from Vectus Biosystems
- Successful Pre-Clinical Trial and Granting of Key Patent
- Appendix 4C - Quarterly Report and Update
- Admission to Official List
- Scientific Paper on Accugen Technology
- Key Accugen Patent Granted in USA
Later from Vectus Biosystems
- Chairmans Address to Shareholders
- CEOs Address to Shareholders
- Response to ASX Appendix 4C Query
- Half Year Report and Appendix 4D
- Response to Appendix 4C Query
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems